Prostaglandin E 2 promotes intestinal tumor growth via DNA methylation

Nature Medicine

Volumn 18, Issue 2, 2012, Pages 224-226

  Xia, Dianren ^a   Wang, Dingzhi ^a   Kim, Sun Hee ^a   Katoh, Hiroshi ^a   Dubois, Raymond N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; CELECOXIB; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROSTAGLANDIN E2; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE 2; PROSTAGLANDIN SYNTHASE; PROTEIN MLH1; UNCLASSIFIED DRUG; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; DNA REPAIR; EPITHELIUM CELL; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; INTESTINE TUMOR; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CELL LINE, TUMOR; DINOPROSTONE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; INTESTINAL NEOPLASMS; MICE; UP-REGULATION;

EID: 84856748026     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2608     Document Type: Article

References (20)

1. Wang, D. & DuBois, R.N. Oncogene 29, 781-788 (2010).
2. Wang, D. & DuBois, R.N. Nat. Rev. Cancer 10, 181-193 (2010).
3. Baba, Y. et al. Cancer Epidemiol. Biomarkers Prev. 19, 822-831 (2010).
4. Slattery, M.L. et al. Int. J. Cancer 120, 656-663 (2007).
5. Kim, M.S., Lee, J. & Sidransky, D. Cancer Metastasis Rev. 29, 181-206 (2010).
6. Kim, Y.H. et al. Genes Chromosom. Cancer 45, 781-789 (2006).
7. Wang, D. et al. Cancer Res. 68, 6468-6476 (2008).
8. De Marzo, A.M. et al. Cancer Res. 59, 3855-3860 (1999).
9. Schmidt, W.M. et al. Mol. Carcinog. 46, 766-772 (2007).
10. Nosho, K. et al. Clin. Cancer Res. 15, 3663-3671 (2009).
11. Ibrahim, A.E. et al. Gut 60, 499-508 (2011).
12. Kanai, Y., Ushijima, S., Kondo, Y., Nakanishi, Y. & Hirohashi, S. Int. J. Cancer 91, 205-212 (2001).
13. Steine, E.J. et al. J. Clin. Invest. 121, 1748-1752 (2011).
14. Lin, H. et al. Mol. Cell Biol. 26, 2976-2983 (2006).
15. Linhart, H.G. et al. Genes Dev. 21, 3110-3122 (2007).
16. Shteper, P.J. et al. Oncogene 22, 7737-7749 (2003).
17. Pakneshan, P., Szyf, M., Farias-Eisner, R. & Rabbani, S.A. J. Biol. Chem. 279, 31735-31744 (2004).
18. Hamm, C.A. et al. PLoS ONE 4, e8340 (2009).
19. Ogino, S. et al. J. Natl. Cancer Inst. 100, 1734-1738 (2008).
20. Ahn, J.B. et al. Cancer 117, 1847-1854 (2011).